Astellas to Discontinue IBS Med Colonel in Product Consolidation

January 24, 2024
Astellas Pharma is discontinuing the sale of its irritable bowel syndrome (IBS) therapy Colonel (polycarbophil calcium). The drug is also sold under a different brand name of Polyful by Viatris Pharmaceuticals Japan, and this product will remain available. Astellas recently...read more